Welcome to our dedicated page for Hippo Hldgs SEC filings (Ticker: HIPOW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The HIPPO HOLDINGS INC WTS (HIPOW) SEC filings page provides access to regulatory documents connected to Hippo Holdings Inc., the underlying issuer whose common stock trades on the New York Stock Exchange under the symbol HIPO. Because HIPOW represents warrants linked to Hippo Holdings Inc., the company’s SEC reports are a primary source of information for understanding developments that may matter to holders of the warrants.
In a Form 8-K, Hippo Holdings Inc. discloses material events such as changes in the size of its Board of Directors, the appointment of new directors, and their assignments to key committees including the Audit, Risk, and Compliance Committee, the Nominating & Corporate Governance Committee, and the Compensation Committee. The filing also outlines the Non-Employee Director Compensation Program, describing annual cash retainers and restricted stock unit (RSU) awards valued based on the average closing trading price of the company’s common stock and subject to vesting conditions.
On this page, users can review filings like Form 8-K to see how Hippo Holdings Inc. reports governance changes, equity-based compensation practices, and other significant corporate actions. Real-time updates from the SEC’s EDGAR system allow investors to track new disclosures as they are filed, while AI-powered summaries help explain the contents of lengthy documents in more accessible language.
In addition to current reports on Form 8-K, this page can surface other key filing types for Hippo Holdings Inc., such as annual and quarterly reports when available, as well as information related to equity awards and potential change-in-control provisions described in the company’s incentive plans. For HIPOW warrant holders, these filings provide important context about the corporate environment and reporting practices of the underlying issuer.
Hippo Holdings (HIPO): Lennar Corporation and affiliated entities filed Amendment No. 4 to Schedule 13D reporting beneficial ownership of 2,169,580 shares of Hippo common stock, representing 8.6% of outstanding shares. The percentage is based on 25,335,179 shares outstanding as of October 29, 2025. One reporting person also holds an irrevocable proxy to vote 16,470 shares, while an agreement limits voting decisions to no more than 9.99% of Hippo’s voting interests.
The filing lists recent open‑market sales by LEN FW Investor, LLC: 119,780 shares on November 7, 2025 at a weighted‑average price of $33.87, and 62,058 shares on November 10, 2025 at $33.59, with additional sales on November 11 and 12, 2025 at weighted‑average prices of $33.22 and $34.06.
Hippo Holdings Inc. insider Guy Zeltser, the company's Chief Financial Officer, reported sales of common stock on 09/17/2025 executed under a Rule 10b5-1 trading plan dated June 18, 2025. The Form 4 shows two sale line items totaling 5,177 shares sold at weighted average prices of $37.4569 and $38.045, leaving the reporting person with 74,861 shares beneficially owned after the transactions.
The filing notes that the remaining holdings include 65,817 RSUs. The reporting person certified the sales and provided undertakings to supply trade-level details on request.
Hippo Holdings Inc. (HIPOW) submitted a Form 144 disclosing a proposed sale of 5,177 common shares by a person for whose account the securities are to be sold. The shares have an aggregate market value of $192,636.17 based on the filing, against 25,028,054 shares outstanding. The proposed approximate sale date is 09/17/2025 on the NYSE. The shares were acquired from the issuer as restricted stock units on 02/15/2025 and were paid in full on that date. The filer reports no securities sold in the past three months for the account.
Hippo Holdings Inc. expanded its Board of Directors from nine to ten members and appointed Laura Hay as a Class I director and Susan Holliday as a Class III director, both effective October 1, 2025. Hay’s initial term runs through the 2028 annual meeting of stockholders, while Holliday’s runs through the 2027 annual meeting.
Both new directors will serve on the Audit, Risk, and Compliance Committee, with Hay also joining the Nominating & Corporate Governance Committee and Holliday joining the Compensation Committee. Each will receive annual cash retainers of $60,000 for Board service, $10,000 for Audit Committee service, plus $4,000 for Hay’s governance role and $6,000 for Holliday’s compensation role.
They will each receive an initial restricted stock unit grant valued at $130,000, prorated from October 1, 2025 to June 3, 2026, vesting in full on June 3, 2026, and will be eligible for recurring annual RSU awards valued at $130,000. All equity awards accelerate in full upon a change in control, and both will enter into the company’s standard indemnification agreement.
Thomas B. Akin and related entities reported collective beneficial ownership of 2,405,304 shares of Hippo Holdings Inc. (HIPO), representing 9.61% of the outstanding common stock. The filing breaks ownership down by holder: Thomas B. Akin directly owns 1,221,832 shares (4.9% of the class), Talkot Fund, LP owns 941,060 shares (3.8%), Talkot Partners V, LP owns 7,412 shares (0.0%), Akin Family Foundation owns 125,000 shares (0.5%), Karen Hochster owns 60,000 shares (0.2%), and Kyle Akin owns 50,000 shares (0.2%). The 9.61% figure is calculated using 25,028,054 shares outstanding as of June 30, 2025 per Hippo’s Form 10-Q. The filing states the securities were not acquired to change or influence control and indicates shared voting and dispositive power over the 2,405,304 shares.